Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe.
Weber, J T
Lopalco, P L
Wasley, A M
AffiliationHealth Protection Surveillance Centre, Dublin, Ireland. email@example.com
Local subject classificationH1N1
Influenza A Virus, H1N1 Subtype
MetadataShow full item record
CitationInfluenza A(H1N1)pdm09 vaccination policies and coverage in Europe. 2012, 17 (4): Euro Surveill.
PublisherEuro surveillance : bulletin Européen sur les maladies transmissibles = European communicable disease bulletin
JournalEuro surveillance : bulletin Européen sur les maladies transmissibles = European communicable disease bulletin
AbstractIn August 2010 the Vaccine European New Integrated Collaboration Effort (VENICE) project conducted a survey to collect information on influenza A(H1N1)pdm09 vaccination policies and vaccination coverage in the European Union (EU), Norway and Iceland. Of 29 responding countries, 26 organised national pandemic influenza vaccination and one country had recommendations for vaccination but did not have a specific programme. Of the 27 countries with vaccine recommendations, all recommended it for healthcare workers and pregnant women. Twelve countries recommended vaccine for all ages. Six and three countries had recommendations for specific age groups in children and in adults, countries for specific adult age groups. Most countries recommended vaccine for those in new risk groups identified early in the pandemic such as morbid obese and people with neurologic diseases. Two thirds of countries started their vaccination campaigns within a four week period after week 40/2009. The reported vaccination coverage varied between countries from 0.4% to 59% for the entire population (22 countries); 3% to 68% for healthcare workers (13 countries); 0% to 58% for pregnant women (12 countries); 0.2% to 74% for children (12 countries). Most countries identified similar target groups for pandemic vaccine, but substantial variability in vaccination coverage was seen. The recommendations were in accordance with policy advice from the EU Health Security Committee and the World Health Organization.
- Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009.
- Authors: Mereckiene J, Cotter S, D'Ancona F, Giambi C, Nicoll A, Levy-Bruhl D, Lopalco PL, Weber JT, Johansen K, Dematte L, Salmaso S, Stefanoff P, Greco D, Dorleans F, Polkowska A, O'Flanagan D, VENICE project gatekeepers group.
- Issue date: 2010 Nov 4
- Seasonal influenza immunisation in Europe. Overview of recommendations and vaccination coverage for three seasons: pre-pandemic (2008/09), pandemic (2009/10) and post-pandemic (2010/11).
- Authors: Mereckiene J, Cotter S, Nicoll A, Lopalco P, Noori T, Weber J, D'Ancona F, Levy-Bruhl D, Dematte L, Giambi C, Valentiner-Branth P, Stankiewicz I, Appelgren E, O Flanagan D, VENICE project gatekeepers group.
- Issue date: 2014 Apr 24
- Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
- Authors: Ryan J, Zoellner Y, Gradl B, Palache B, Medema J
- Issue date: 2006 Nov 17
- How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015.
- Authors: Jorgensen P, Mereckiene J, Cotter S, Johansen K, Tsolova S, Brown C
- Issue date: 2018 Jan 25
- Pandemic vaccination strategies and influenza severe outcomes during the influenza A(H1N1)pdm09 pandemic and the post-pandemic influenza season: the Nordic experience.
- Authors: Gil Cuesta J, Aavitsland P, Englund H, Gudlaugsson Ó, Hauge SH, Lyytikäinen O, Sigmundsdóttir G, Tegnell A, Virtanen M, Nordic influenza comparison group., Krause TG
- Issue date: 2016 Apr 21